Abstract
A facile synthesis of the disubstituted 1H-indole-2-carboxamides (6a-h) is described. Readily available 4-benzyloxy-3-methoxybenzaldehyde is converted to the parent acid (12) by nucleophilic attack of the azido-ester (9) and cyclization of the propenoic methyl ester (10). The target compounds (6a-d) were obtained by amidation of (12) with the appropriate primary amine. The new 6-hydroxy analogs (6e-h) were prepared by benzyl deprotection of (6a-d). The cytotoxicity of the new molecules was evaluated in the human non-small lung cancer cell line NSCLC-N16-L16 in vitro. One compound (6d) showed satisfactory activity (IC50 = 13.9 μM) worthy of further study. It is noteworthy that few agents are clinically effective against human non-small lung cancer, and thus there is a need for novel agents for use in this disease.
Keywords: Disubstituted 1H-indole-2-carboxamides, synthesis, cytotoxicity
Letters in Drug Design & Discovery
Title: C5,C6-Disubstituted 1H-Indole-2-Carboxamides: Synthesis and Cytotoxic Activity in the Human Non-Small Lung Cancer Cell Line NSCLC-N16-L16
Volume: 3 Issue: 1
Author(s): Andrew Tsotinis, Maria Gerasimopoulou, Margarita Vlachou, Dimitri Moreau and Christos Roussakis
Affiliation:
Keywords: Disubstituted 1H-indole-2-carboxamides, synthesis, cytotoxicity
Abstract: A facile synthesis of the disubstituted 1H-indole-2-carboxamides (6a-h) is described. Readily available 4-benzyloxy-3-methoxybenzaldehyde is converted to the parent acid (12) by nucleophilic attack of the azido-ester (9) and cyclization of the propenoic methyl ester (10). The target compounds (6a-d) were obtained by amidation of (12) with the appropriate primary amine. The new 6-hydroxy analogs (6e-h) were prepared by benzyl deprotection of (6a-d). The cytotoxicity of the new molecules was evaluated in the human non-small lung cancer cell line NSCLC-N16-L16 in vitro. One compound (6d) showed satisfactory activity (IC50 = 13.9 μM) worthy of further study. It is noteworthy that few agents are clinically effective against human non-small lung cancer, and thus there is a need for novel agents for use in this disease.
Export Options
About this article
Cite this article as:
Tsotinis Andrew, Gerasimopoulou Maria, Vlachou Margarita, Moreau Dimitri and Roussakis Christos, C5,C6-Disubstituted 1H-Indole-2-Carboxamides: Synthesis and Cytotoxic Activity in the Human Non-Small Lung Cancer Cell Line NSCLC-N16-L16, Letters in Drug Design & Discovery 2006; 3 (1) . https://dx.doi.org/10.2174/157018006775240980
DOI https://dx.doi.org/10.2174/157018006775240980 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pancreatic Cancer and Personalized Medicine: Can Genomics Facilitate Early Diagnosis or Improve Therapeutic Outcomes?
Current Pharmacogenomics and Personalized Medicine Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications
Current Pharmaceutical Design Genetics and Genomics Interventions for Promoting Millets as Functional Foods
Current Genomics Effects and Role of Multikinase Inhibitors in Thyroid Cancer
Current Pharmaceutical Design YB-1 Activities in Oncogenesis: Transcription and Translation
Current Cancer Therapy Reviews HIF-1 Signaling in Drug Resistance to Chemotherapy
Current Medicinal Chemistry Lectins in Human Cancer: Both a Devil and an Angel?
Current Protein & Peptide Science Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
Current Cancer Drug Targets A Hypothesis for the Relationship between Depression and Cancer: Role of Ca2+/cAMP Signalling
Anti-Cancer Agents in Medicinal Chemistry Calcium-calpain Dependent Pathways Regulate Vesiculation in Malignant Breast Cells
Current Cancer Drug Targets MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Current Medicinal Chemistry The Role of P2X Receptors in Bone Biology
Current Medicinal Chemistry Current Developments in the Synthesis and Biological Activity of Aza-C-Nucleosides:Immucillins and Related Compounds
Current Medicinal Chemistry Electrochemical Study of Ellipticine Interaction with Single and Double Stranded Oligonucleotides
Anti-Cancer Agents in Medicinal Chemistry Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
Current Cancer Drug Targets Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review
Current Genomics Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Current Medicinal Chemistry